Powder Delivery TRIZ Cases

A tryptophan formulation with B vitamins and carbohydrates enhances brain transport.

Inhaled omega-3 fatty acid carriers deliver therapeutic doses directly to lung tissue.

Argonaute-2 protein binds microRNA to form biocompatible nanoparticles, reducing toxicity from cationic carriers while protecting genetic cargo.

Densely PEGylated gene vectors overcome the electrostatically charged extracellular matrix barrier to achieve widespread distribution in brain parenchyma.

TBK-1 antagonists suppress inflammatory responses while degradative agonists reduce bacterial burden.

Peptide docking vehicle conjugates siRNA to target hepatocytes, silencing angiotensinogen mRNA to treat hypertension without counterbalancing mechanisms.

Composite nanoparticles integrate cationic lipids with cell-penetrating peptides to overcome low transfection efficiency in non-viral gene therapy.

Particulate extrusion encapsulation product using a glassy matrix of modified starch and insoluble fiber.

A bi-specific antibody links PEGylated nanoparticles to tumor antigens via distinct binding sites.

Nanoparticle drug conjugates overcome limited CNS penetration by transporting small molecule inhibitors across the blood-brain barrier.

Replacing thermal methods with chemical agents eliminates scarring and ensures uniform ablation.

Cyanine dye nanoparticles aggregate in aqueous media to resolve specificity limits in complex tissue environments.

An effervescent oral composition uses sugar alcohol fillers and active ingredients to create a carbon dioxide release mechanism in the mouth.

Lyophilized saccharide-degrading enzyme unit dose formulation suppresses titer reduction and minimizes wastage.

Traditional Chinese medicine composition reduces blood lipids and triglycerides through synergistic herbal extracts.

A gold nanoparticle-carbocyanine dye conjugate enables near-infrared fluorescence imaging and selective RF-induced hyperthermia.

A recombinant surfactant protein D formulation maintains oligomerization states through specific buffer conditions.

Charged amino acids mediate electrostatic interactions to inhibit CD-RAP aggregation, resolving stability trade-offs during storage and freeze-thaw cycles.

Controlled excipient particle size balances inhalable proportion and flow properties for consistent lung delivery.

Photo-activated super elastic epoxy hydrogel polymers reduce power consumption for industrial scalability.

Crosslinked cyclic molecules create stable nanostructures that resist solvent degradation while increasing inclusion space.

Impregnate porous carriers with drug solutions to achieve less than 3% API content variability, resolving blend uniformity challenges at low concentrations.

A hairpin-like oligonucleotide conjugates passenger and guide strands to a nanoparticle core via radial orientation.

Inhibiting UFM1 and UFL1 proteins disrupts ufmylation pathways, reducing DNA damage response capacity and sensitizing cancer cells to radiation or chemotherapy.

An oligonucleotide shell protects proteins from protease degradation and aggregation while enabling precise lattice engineering via DNA hybridization.

Reducing hemostatic powder particle size below 48 microns improves adhesion to vertical surfaces, preventing waste while arresting bleeding effectively.

Selective binding molecules neutralize free IL-18 without engaging the IL-18BP complex, reducing therapeutic doses and side effects.

Multiple harvesting stages and pH-controlled chromatography boost viral titers while reducing process impurities.

Fusion protein self-assembles into immunogenic macromolecules that overcome immune tolerance to treat established HPV infections and associated cancers.

Composite glucose anhydrous and lactose carriers resolve content uniformity contradictions by absorbing moisture and preventing particle agglomeration.

A lyophilized powder containing a boron complex formed by dehydration condensation of dihydroxyboryl compounds and sugars.

A TLR2 agonist lipopeptide conjugated with polyethyleneglycol targets the respiratory tract to reduce viral load and inflammatory mediators.

A cell-free matrix-gel graft recruits progenitor cells via endogenous synovial fluid.

Segmenting carrier preparation from isotope loading resolves the trade-off between manufacturing efficiency and radionuclide selection flexibility.

Localized inhalation of thyroid derivatives treats pulmonary fibrosis while avoiding systemic side effects.

Parabacteroides distasonis addresses ineffective standard therapies by modulating the gut-brain axis to protect against reactive oxygen species.

Segmented ocular implant elutes therapeutic agents through selective membranes into the aqueous humor stream for targeted delivery.

Lentiviral transduction of CHO-K1 cells with optimized coding sequences eliminates batch variations and serum extraction while ensuring high productivity.

A chlorine-free poly-oxygenated aluminum hydroxide clathrate dissolves oxygen gas molecules into a soluble fluid matrix.

Composite polyorthoester formulations sustain bupivacaine release to provide eight-day pain relief without opioid side effects.

PEG-PBAE copolymers form stable polyplexes that reduce cytotoxicity and protein adsorption.

Lyophilizing iron oxide nanoparticles with cryo-protectants maintains chain arrangement and magnetic properties, preventing coating degradation in water.

Disposable flexible bags resolve cross-contamination and cleaning bottlenecks while ensuring uniform moisture egress during large-scale lyophilisation.

pH-sensitive metal nanoparticles aggregate in acidic environments to enable targeted photothermal therapy.

Segmented reactor units enable precise size control while expanding solvent applicability beyond atmospheric boiling limits.

Polylysine-coated iron oxide nanoparticles convert radiation-induced immune suppression into type I interferon activation, transforming cold tumors.

Aerosolized organic acid formulation neutralizes airborne allergens by generating fine droplets that overcome surface-only limitations of existing sprays.